Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127981751 | 12798175 | 1 | I | 2016 | 20160928 | 20160930 | 20160930 | EXP | NL-ROCHE-1836828 | ROCHE | 0.00 | F | Y | 0.00000 | 20160930 | CN | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127981751 | 12798175 | 1 | PS | RIVOTRIL | CLONAZEPAM | 1 | Oral | U | 17533 | .5 | MG | TABLET | QD | ||||||
| 127981751 | 12798175 | 2 | SS | RIVOTRIL | CLONAZEPAM | 1 | U | 17533 | |||||||||||
| 127981751 | 12798175 | 3 | SS | RIVOTRIL | CLONAZEPAM | 1 | Oral | 2.5 MG/ML | U | 17533 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127981751 | 12798175 | 1 | Poor quality sleep |
| 127981751 | 12798175 | 2 | Poor quality sleep |
| 127981751 | 12798175 | 3 | Poor quality sleep |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127981751 | 12798175 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127981751 | 12798175 | Anxiety | |
| 127981751 | 12798175 | Drug dependence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |